학술논문

Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension
Document Type
Journal
Source
EUROPEAN JOURNAL OF PHARMACOLOGY; JUL 15 2022, 927 p175048 12p.
Subject
Language
English
ISSN
18790712